Medicare patients who lack prescription drug coverage are much less likely to use statins than those who do have insurance to cover drug costs. That's the finding of a new study published in the Journal of the American Medical Association.
Researchers evaluated more than 1900 older people (age 66 or older) with a history of coronary heart disease or previous heart attack as part of a regular Medicare survey. They divided the patients into two groups: (1) those who have Medicare with no drug coverage or supplemental insurance they bought themselves, and (2) those who have Medicare plus drug coverage from Medicaid, Medigap, other public program, a health maintenance organization, or an employer-sponsored plan.
They quantified the percentage of patients who take three drugs commonly prescribed for heart disease:
| |
Drug |
Medicare with drug coverage |
Medicare without drug coverage |
| |
| |
Statins |
27.4% |
4.1% |
| |
Beta-blockers |
36.1% |
20.7% |
| |
Nitrates |
38.0% |
20.4% |
The authors of the report note that Medicare beneficiaries who lack drug coverage have disproportionately large drug expenditures and lower use rates of statins, a class of relatively expensive dugs that improve survival. They suggest that information such as this would be useful in designing a Medicare drug program.
Related information
Medications
Source: Federman AD, Adams AS, Ross-Degnan D, et al. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA, Oct. 10, 2001;286(14):1732-1739. (Abs.)